Skip to main content

HealthDecision

By Laura Lovett | 05:17 pm | January 24, 2019
Also: 23andMe gets FDA nod for direct-to-consumer test for hereditary colorectal cancer syndrome; Mobile Heartbeat announces integration with Imprivata.